• Home
• News
• About Us
• Contact

Search

Tag Cloud

anthrax Strategic National Stockpile Training exercise Bioterror Biomagnetics National Research Council Homeland Security Biodefense lab Army Medical Research Institute antibiotics Emergency preparedness research Bioweapons NIAID smallpox Detection technology CDC TSA Defense Dept IAEM FEMA immunization Ebola Ricin Hendra Plague treaty West Nile Camouflage Paint Marburg antidote weapons destruction Sarin VHF viruses chemical disposal dna technology prevention Robotics Technology research grants tularemia weapons control foot and mouth disease decontamination E. coli Iraq missile defense Bio-Rescue Dengue fever Botulinum toxin antiviral molecular diagnostics Infectious disease

Subscribe to our newsletter

RSS Feed

Indian navy to develop NBC training facility
by Paul Tinder on March 9, 2010

India's navy has begun the creation of a nuclear, biological and chemical defense training facility.

Report highlights misuse of funds for homeland security
by Paul Tinder on March 1, 2010

A report released by the Washington-based Center for Public Integrity and the Center for Investigative Reporting, based in Berkeley, California, includes an interactive map to detail the use of homeland security readiness in all 50 states.

Japanese official says police warned of 1995 sarin gas attack
by Paul Tinder on February 23, 2010

A former Japanese National Police Agency chief has revealed in an interview that a tip was received prior to the 1995 Tokyo subway sarin gas attack that killed 12 people.

Is PharmAthene Pulling Strings to Win Contracts?
by Paul Tinder on February 12, 2010

BigGovernment.com reports that PharmAthene is enjoying preferential treatment from the federal government, thanks to its close connections to recently deceased Congressman John Murtha and DHS Under Secretary Tara O’Toole.

Emergent BioSolutions leading the way in Michigan's drive to propserity
by Paul Tinder on February 4, 2010

The state of Michigan, facing the loss of manufacturing jobs, has turned its eye toward the future and begun exploring innovative methods of restoring prosperity to the region.

N.H. anthrax woman responding to questions
by Paul Tinder on January 28, 2010

New Hampshire's deputy state epidemiologist has announced that, as of Wednesday, the woman who contracted a rare form of anthrax almost two months ago, despite remaining hospitalized, is now able to answer state health officials' questions.

New chamber built to simulate battlefield for chemical agent sensor tests
by Paul Tinder on January 26, 2010

A first-of-its-kind chamber has been developed by Applied Physics Laboratory engineers to test, under realistic battlefield conditions, the viability of sensors designed to detect chemical warfare agents.

Fears rise that Scotland anthrax outbreak spreading
by Paul Tinder on January 8, 2010

The anthrax outbreak among intravenous drug users in Scotland has now caused six deaths and infected a total of 12 people, health officials have revealed.

Second anthrax scare in Montgomery, Alabama
by Paul Tinder on January 7, 2010

A second anthrax scare at Montgomery, Alabama's municipal court building is not, the FBI has said, related to a string of similar letters sent to congressional offices around the state.

Third White House gate crasher raises terror threat anew
by Paul Tinder on January 5, 2010

The Secret Services has revealed that, in addition to Tareq and Michaele Salahi, a third person entered President Obama's Indian state dinner without an invitation, raising fears of how security is run for the president.

Blast in India believe to be at biolab
by Paul Tinder on December 31, 2009

A high intensity explosion at a chemical laboratory inside India's Bhabha Atomic Research Centre resulted in the death of two junior scientists with an initial investigation focusing on biological and chemical agent experiments.

PDAs might increase survival during bioattack
by Paul Tinder on December 29, 2009

A report in the International Journal of Healthcare Technology and Management says that utilizing a digital checklist for patients who are being administered emergency drugs during a bioterrorist attack can reduce the fatigue factor and save lives.

Maine to receive more than $3 million to aid bioterror research
by Paul Tinder on December 21, 2009

More than $3 million will be set aside for bioterrorism research in Maine by the Department of Defense's new appropriation bill, which has been sent to President Barack Obama for his signature.

New York scores high on report over bio-preparedness
by Paul Tinder on December 16, 2009

New York has been named one of eight states to have met nine of 10 preparedness measures in the face of a pandemic, a first step in fighting a potential biological attack.

Regional stockpiles could aid Europe in event of bioattack
by Paul Tinder on December 15, 2009

A plan to ensure Europe is prepared for a biologic attack has been laid out by Allen Shofe, senior vice president of public affairs at Emergent BioSoloutions, as part of the Security & Defence Agenda's "Raising Biopreparedness Levels in Europe" report.

Combating bioterrorism needs to be a collaborative effort, ISBI founder says
by Paul Tinder on December 10, 2009

"I would argue bioterrorism is the most viable threat of an enormous magnitude, far more than a nuclear attack," Barry Kellman, president of the International Security & Biopolicy Institute said. "There are many threats.

Warning issued to synthetic DNA manufacturers
by Paul Tinder on December 9, 2009

The Department of Health and Human Services has warned U.S. businesses trading in DNA to be on guard against abuses leading to bioterrorism.

Anthrax drug Anthim shown to be effective in rabbit and primate studies
by Paul Tinder on December 8, 2009

The biopharmaceutical company Elusys Therapeutics, Inc., has announced positive results for its Anthim anthrax anti-toxin program.

New guidelines for genetic screening to prevent bioterrorism split scientists
by Paul Tinder on December 7, 2009

New guidelines have been presented for genetic screening to prevent the possibility of bioterrism, dividing the opinions of scientists on the matter.

Australia company looking to take over biological weapon stopping fabric coating company
by Paul Tinder on December 4, 2009

ETW Corporation has begun the investigative process for taking over a United Kingdom-based company that carries the rights to a fabric coating process that protects soldiers against chemical and biological threats.

Biomagentics Diagnostics finalizes agreement for fiber optic biosensor
by Paul Tinder on December 3, 2009

Biomagnetics Diagnostics, Corp., has announced the finalization of a "Patent License Agreement" with Los Alamos National Security.

Major smallpox vaccine order announcement expected
by Paul Tinder on November 27, 2009

The biodefense company SIGA Technologies, which engages in the discovery, development and commercialization of products for use in defense against biological warfare agents, is expected to make a major announcement.

Export of bioweapon technology to India to remain restricted
by Paul Tinder on November 24, 2009

The United States has maintained restrictions on the export of as many as 11 of its 16 dual use technology regimes to India, including on dual use technology in chemical and biological weapons.

Affect of new legislation on science community questioned
by Paul Tinder on November 20, 2009

The ability of U.S. laboratories to conduct important biodefense research could be impaired by mandates included in new federal legislation, the American Association for the Advancement of Science has announced.

Anthrax drug maker questions approval process for drug
by Paul Tinder on November 19, 2009

The delay to Human Genome Sciences' experimental anthrax drug appears inconsistent with published final rules governing the development of new drugs by the FDA, an HGS spokesperson has said.

Primate research center granted stimulus funds for Marburg and Ebola vaccine study
by Paul Tinder on November 18, 2009

Federal stimulus money has been granted to the New England Primate Research Center for investigations and a contract tied to developing a vaccine for the Marburg and Ebola viruses.

New bioterror response research institute opens near Washington, D.C.
by Paul Tinder on November 16, 2009

The Stanford Research Institute International's new research facility in Harrisonburg, Va., has officially opened after four years of planning and construction.

Researcher says ICC needs stronger biological, chemical weapons provisions
by Paul Tinder on November 13, 2009

This month, the States Parties to the International Criminal Court will come together in The Hague to prepare for their review of the Rome Statute, the ICC's governing document, in Uganda in 2010.

Suspicious envelope found at 6th U.N. mission
by Paul Tinder on November 11, 2009

NEW YORK — A sixth U.N. mission in New York has received an envelope filled with a suspicious white powder, Reuters reported Nov. 11.

Suspicious envelopes sent to U.N. missions apparently contained flour
by Paul Tinder on November 10, 2009

NEW YORK — Looks like flour was the suspicious powder inside those envelopes sent to several United Nations missions.

GTCBio vaccine conference offers updates on biodefense policies
by Paul Tinder on November 9, 2009

WASHINGTON, D.C. — GTCbio’s seventh annual Vaccines: All Things Considered conference is scheduled for Nov 9-10 in Washington.

European states press to make chemical, bioweapons use war crimes
by Paul Tinder on November 6, 2009

The Netherlands is expected on Nov. 9 to request that the International Criminal Court expand its definition of what actions constitute war crimes to include the use of chemical and biological weapons.

U.S. contingency plans with S. Korea to secure N. Korean WMD
by Paul Tinder on November 5, 2009

The U.S. military would take the lead in destroying or safeguarding North Korean weapons of mass destruction should the isolated Asian state fall into chaos.

Calmune, Crucell enter research, development deal
by Paul Tinder on November 4, 2009

Calmune Corp. announced Nov. 3 that it has entered an agreement with Crucell N.V. that will focus on research development, production and marketing of vaccines, proteins and antibodies that prevent and/or treat infectious diseases.

McCaskill amendment to increase security at research labs
by Paul Tinder on November 2, 2009

WASHINGTON, D.C. — U.S. Sen. Claire McCaskill added an amendment to the Weapons of Mass Destruction Prevention and Preparedness Act of 2009 that would prevent labs from doing research on high-risk biological agents if they violate security requirements.

New video supports enhanced U.S. vaccine preparedness
by Paul Tinder on October 29, 2009

WASHINGTON, D.C. — The current shortage of H1N1 vaccine underscores the severe lack of U.S. preparedness in responding to pandemics, whether through natural disease transmission or manmade bioterrorist attacks.

Immune system quirk could lead to effective tularemia vaccine
by Paul Tinder on October 27, 2009

Immunologists have found a unique quirk in the way the immune system fends off bacteria that could lead to vaccines to prevent tularemia infection of the lungs.

Saudi Arabia to Host Workshop on Biological Weapons Dangers
by Paul Tinder on October 19, 2009

Saudi Arabia this week is scheduled to host a U.N. workshop on the dangers posed by biological weapons.

European Commission hopes to see action plan adopted by year end
by Paul Tinder on October 16, 2009

The European Commission hopes its CBRN action plan, designed to improve the EU’s defenses against the threat of a chemical, nuclear or bioterrorism attack, will be adopted by member states by the end of the year.

New York prepares response to anthrax attack
by Paul Tinder on September 14, 2009

NEW YORK – The City’s Department of Health tested its readiness to respond to an anthrax attack with an antibiotics and vaccine distribution drill this week at a Lower East Side school.

It can happen here, and it pays to be ready
by Paul Tinder on September 14, 2009

PALM BEACH – Don’t think it can’t happen here. It can. And, if it does, Palm Beach Fire-Rescue will be ready for it.

Two-day training session simulates pneumonic plague attack
by Paul Tinder on September 14, 2009

GENEVA – Members of US humanitarian aid groups learned how to deter biological terrorist attacks during a recent two-day training session in Montreux, Switzerland.

Emergent BioSolutions launches biothrax.com
by Paul Tinder on May 8, 2009

ROCKVILLE, Md. — Emergent BioSolutions Inc. announced the launch of www.biothrax.com, a website that provides information about BioThrax, the only vaccine licensed by the U.S. FDA for the prevention of anthrax infection.

Emergent BioSolutions establishes office in Germany
by Paul Tinder on August 23, 2005

GAITHERSBURG, Md. — Emergent BioSolutions on Aug. 23, 2005, announced the opening of an office in Munich, Germany, dedicated to the expansion of markets throughout Europe and Asia.